TipRanks
Canopus Biopharma Inc (CBIA)
OTHER OTC:CBIA
US Market
CBIA
Canopus Biopharma
RESEARCH TOOLSreports

Canopus Biopharma (CBIA) Income Statement

19 Followers

Canopus Biopharma Income Statement

Last quarter (Q2 2023), Canopus Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Canopus Biopharma's net income was $-203.95K. See Canopus Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Aug 22Aug 21
Total Revenue
$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00
Operating Expenses
$ 764.56K$ 1.75K
Depreciation and Amortization
$ 228.49K$ 236.56K
EBITDA
$ -764.56K$ -1.76K
Operating Income
$ -764.56K$ -1.76K
Other Income/Expenses
$ -145.00$ 5.00
Pretax Income
$ -764.71K$ -1.75K
Net Income
$ -764.71K$ -1.75K
Per Share Metrics
Basic EPS
$ -0.01$ 0.00
Diluted EPS
$ -0.01$ 0.00
Weighted Average Shares Outstanding
 109.62M 98.24M
Weighted Average Shares Outstanding (Diluted)
 109.62M 98.24M
Currency in USD

Canopus Biopharma Earnings and Revenue History